KemPharm
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch KemPharm and buy or sell other stocks, ETFs, and their options commission-free!About KMPH
Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia.
CEONeil F. McFarlane
CEONeil F. McFarlane
Employees59
Employees59
HeadquartersCelebration, Florida
HeadquartersCelebration, Florida
Founded2006
Founded2006
Employees59
Employees59
KMPH Key Statistics
Market cap481.73M
Market cap481.73M
Price-Earnings ratio-6.62
Price-Earnings ratio-6.62
Dividend yield—
Dividend yield—
Average volume1.62M
Average volume1.62M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$12.55
52 Week high$12.55
52 Week low$5.45
52 Week low$5.45
People also own
Based on the portfolios of people who own KMPH. This list is generated using Robinhood data, and it’s not a recommendation.